Thank you for the question.
I will just refer to a program that we have called project Orbis, in which we work with other regulators that approve these products to expedite the number of products that come to Canada specifically for cancer treatments.
Over the last year—2025—for example, 16 of these products have been approved, and over the last six years, 94 of them have been approved. These are all oncology products that have been approved for the Canadian market and eventually made available to Canadians.